Form 8-K - Current report:
SEC Accession No. 0001493152-24-035076
Filing Date
2024-09-05
Accepted
2024-09-05 06:15:40
Documents
13
Period of Report
2024-09-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36931
  Complete submission text file 0001493152-24-035076.txt   216214

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hepa-20240903.xsd EX-101.SCH 3027
3 XBRL LABEL FILE hepa-20240903_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE hepa-20240903_pre.xml EX-101.PRE 24603
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3859
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 241279777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)